These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 29404280)

  • 41. Mechanisms of NK cell-macrophage Bacillus anthracis crosstalk: a balance between stimulation by spores and differential disruption by toxins.
    Klezovich-Bénard M; Corre JP; Jusforgues-Saklani H; Fiole D; Burjek N; Tournier JN; Goossens PL
    PLoS Pathog; 2012 Jan; 8(1):e1002481. PubMed ID: 22253596
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anthrax lethal toxin paralyzes neutrophil actin-based motility.
    During RL; Li W; Hao B; Koenig JM; Stephens DS; Quinn CP; Southwick FS
    J Infect Dis; 2005 Sep; 192(5):837-45. PubMed ID: 16088833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.
    Stokes MG; Titball RW; Neeson BN; Galen JE; Walker NJ; Stagg AJ; Jenner DC; Thwaite JE; Nataro JP; Baillie LW; Atkins HS
    Infect Immun; 2007 Apr; 75(4):1827-34. PubMed ID: 17145938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bacillus anthracis' lethal toxin induces broad transcriptional responses in human peripheral monocytes.
    Chauncey KM; Lopez MC; Sidhu G; Szarowicz SE; Baker HV; Quinn C; Southwick FS
    BMC Immunol; 2012 Jul; 13():33. PubMed ID: 22747600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bacillus anthracis lethal toxin negatively modulates ILC3 function through perturbation of IL-23-mediated MAPK signaling.
    Seshadri S; Allan DSJ; Carlyle JR; Zenewicz LA
    PLoS Pathog; 2017 Oct; 13(10):e1006690. PubMed ID: 29059238
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cutting edge: resistance to Bacillus anthracis infection mediated by a lethal toxin sensitive allele of Nalp1b/Nlrp1b.
    Terra JK; Cote CK; France B; Jenkins AL; Bozue JA; Welkos SL; LeVine SM; Bradley KA
    J Immunol; 2010 Jan; 184(1):17-20. PubMed ID: 19949100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a novel chimeric PA-LF antigen of Bacillus anthracis, its immunological characterization and evaluation as a future vaccine candidate in mouse model.
    Varshney A; Kumar M; Nagar DP; Pal V; Goel AK
    Biologicals; 2019 Sep; 61():38-43. PubMed ID: 31416791
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
    Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential role of autophagy in the bactericidal activity of human PMNs for Bacillus anthracis.
    Ramachandran G; Gade P; Tsai P; Lu W; Kalvakolanu DV; Rosen GM; Cross AS
    Pathog Dis; 2015 Dec; 73(9):ftv080. PubMed ID: 26424808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis.
    Welkos SL; Friedlander AM
    Microb Pathog; 1988 Jan; 4(1):53-69. PubMed ID: 3143893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.
    Dumas EK; Gross T; Larabee J; Pate L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Collins LC; Spooner CE; Chen H; Ballard J; James JA; Farris AD
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877928
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of deletion of the edema factor on Bacillus anthracis pathogenicity in guinea pigs and rabbits.
    Levy H; Weiss S; Altboum Z; Schlomovitz J; Rothschild N; Glinert I; Sittner A; Kobiler D
    Microb Pathog; 2012 Jan; 52(1):55-60. PubMed ID: 22020310
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection.
    Reed MD; Wilder JA; Mega WM; Hutt JA; Kuehl PJ; Valderas MW; Chew LL; Liang BC; Squires CH
    PLoS One; 2015; 10(7):e0130952. PubMed ID: 26207820
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bacillus anthracis genomic DNA enhances lethal toxin-induced cytotoxicity through TNF-α production.
    Jeon JH; Kim YH; Choi MK; Kim KA; Lee HR; Jang J; Kim YR; Chun JH; Eo SK; Kim TS; Rhie GE
    BMC Microbiol; 2014 Dec; 14():300. PubMed ID: 25472474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new triple chimeric protein as a high immunogenic antigen against anthrax toxins: theoretical and experimental analyses.
    Abdous M; Hasannia S; Salmanian AH; Shahryar Arab S; Shali A; Alizadeh GA; Hajizadeh A; Khafri A; Mohseni A
    Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):25-31. PubMed ID: 30621469
    [No Abstract]   [Full Text] [Related]  

  • 56. Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R.
    Zai X; Zhang J; Liu J; Liu J; Li L; Yin Y; Fu L; Xu J; Chen W
    Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26927174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anthrax lethal and edema toxins in anthrax pathogenesis.
    Liu S; Moayeri M; Leppla SH
    Trends Microbiol; 2014 Jun; 22(6):317-25. PubMed ID: 24684968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Production of Functionally Active and Immunogenic Non-Glycosylated Protective Antigen from Bacillus anthracis in Nicotiana benthamiana by Co-Expression with Peptide-N-Glycosidase F (PNGase F) of Flavobacterium meningosepticum.
    Mamedov T; Chichester JA; Jones RM; Ghosh A; Coffin MV; Herschbach K; Prokhnevsky AI; Streatfield SJ; Yusibov V
    PLoS One; 2016; 11(4):e0153956. PubMed ID: 27101370
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential contribution of Bacillus anthracis toxins to pathogenicity in two animal models.
    Levy H; Weiss S; Altboum Z; Schlomovitz J; Glinert I; Sittner A; Shafferman A; Kobiler D
    Infect Immun; 2012 Aug; 80(8):2623-31. PubMed ID: 22585968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potentiation of anthrax vaccines using protective antigen-expressing viral replicon vectors.
    Wang HC; An HJ; Yu YZ; Xu Q
    Immunol Lett; 2015 Feb; 163(2):206-13. PubMed ID: 25102364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.